These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 20045460)
1. Preventive effects of syngeneic bone marrow transplantation on diabetic nephropathy in mice. Ouyang J; Hu G; Wen Y; Zhang X Transpl Immunol; 2010 Feb; 22(3-4):184-90. PubMed ID: 20045460 [TBL] [Abstract][Full Text] [Related]
2. Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels. Jiao B; Wang YS; Cheng YN; Gao JJ; Zhang QZ Biosci Trends; 2011 Aug; 5(4):173-81. PubMed ID: 21914953 [TBL] [Abstract][Full Text] [Related]
3. Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice. Wen Y; Ouyang J; Li W; Chen J; Liu Y; Meng L; Zhang H; Zhou X Transplant Proc; 2009 Jun; 41(5):1801-7. PubMed ID: 19545732 [TBL] [Abstract][Full Text] [Related]
4. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation. Wen Y; Ouyang J; Yang R; Chen J; Liu Y; Zhou X; Burt RK Biochem Biophys Res Commun; 2008 Sep; 374(2):282-7. PubMed ID: 18625200 [TBL] [Abstract][Full Text] [Related]
5. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes. Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738 [TBL] [Abstract][Full Text] [Related]
6. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes. Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080 [TBL] [Abstract][Full Text] [Related]
7. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Ohshiro Y; Ma RC; Yasuda Y; Hiraoka-Yamamoto J; Clermont AC; Isshiki K; Yagi K; Arikawa E; Kern TS; King GL Diabetes; 2006 Nov; 55(11):3112-20. PubMed ID: 17065350 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats. Yuan J; Jia R; Bao Y J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099 [TBL] [Abstract][Full Text] [Related]
9. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress. Zhang M; Hagiwara S; Matsumoto M; Gu L; Tanimoto M; Nakamura S; Kaneko S; Gohda T; Qian J; Horikoshi S; Tomino Y Metabolism; 2006 Dec; 55(12):1590-8. PubMed ID: 17142129 [TBL] [Abstract][Full Text] [Related]
10. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Hamada Y; Fukagawa M Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205 [TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. Hagiwara S; Makita Y; Gu L; Tanimoto M; Zhang M; Nakamura S; Kaneko S; Itoh T; Gohda T; Horikoshi S; Tomino Y Nephrol Dial Transplant; 2006 Mar; 21(3):605-15. PubMed ID: 16282336 [TBL] [Abstract][Full Text] [Related]
12. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway. Li C; Cai F; Yang Y; Zhao X; Wang C; Li J; Jia Y; Tang J; Liu Q Eur J Pharmacol; 2010 Dec; 649(1-3):382-9. PubMed ID: 20854812 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Hamada Y; Miyata S; Nii-Kono T; Kitazawa R; Kitazawa S; Higo S; Fukunaga M; Ueyama S; Nakamura H; Yodoi J; Fukagawa M; Kasuga M Nephrol Dial Transplant; 2007 Jun; 22(6):1547-57. PubMed ID: 17360766 [TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression. Zheng M; Ye S; Zhai Z; Chen Y; Li X; Yang G; Fan A; Wang Y J Diabetes Complications; 2009; 23(2):124-9. PubMed ID: 18413206 [TBL] [Abstract][Full Text] [Related]
16. Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats. Fujita A; Sasaki H; Doi A; Okamoto K; Matsuno S; Furuta H; Nishi M; Nakao T; Tsuno T; Taniguchi H; Nanjo K Diabetes Res Clin Pract; 2008 Jan; 79(1):11-7. PubMed ID: 17897750 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379 [TBL] [Abstract][Full Text] [Related]
18. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model. Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378 [TBL] [Abstract][Full Text] [Related]
19. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production. Krag S; Nyengaard JR; Wogensen L Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Elmarakby AA; Ibrahim AS; Faulkner J; Mozaffari MS; Liou GI; Abdelsayed R Vascul Pharmacol; 2011; 55(5-6):149-56. PubMed ID: 21807121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]